text: Icahn: Scoffs At Mylan-King Pharma Merger In SEC Proxy Not buying it. Megafinancier Carl Icahn has made it clear: He #39;s still opposed to Mylan Laboratories #39; (nyse: MYL - news - people ) proposed acquisition of King Pharmaceuticals (nyse: KG - news - people ). Despite 